Home Page Contact Us Site Map
Home    Articles      Facts      Charity      Lawyers      Directory      Add a Link  &nbs
 
Alimta with cisplatin
The Food and Drug Administration (FDA) approved Alimta (pemetrexed disodium) for ...more
World Trade Center Asbestos
EPA collected wipe samples in a subset of the households that were...more
Diseases Caused By Asbestos Exposure
Pleural plaque is not cancer, and it does not cause cancer...more
Mesothelioma: A Killer Lurks in the Lungs

Back to Health News Page

Home Page

 

British, French drug firms lead on marijuana tests

Last Updated: 2004-09-30 10:17:30 -0400 (Reuters Health)

By Leonard Anderson

SAN FRANCISCO (Reuters) - British and French pharmaceutical companies are racing ahead of their U.S. counterparts to develop new drugs containing marijuana to relieve pain and treat a wide range of illnesses because marijuana is illegal in the United States, scientific researchers said on Wednesday.

"The plant that nature gave us has significant potential therapeutic effects," said Dr. Donald Abrams, professor of clinical medicine at the University of California-San Francisco and a marijuana researcher.

But Abrams and two other scientists said drug development in the United States is lagging because the federal government has made marijuana -- Cannabis sativa -- an illegal "controlled substance."

The U.S. government restricts medical research involving marijuana and fights to shut down groups dispensing it to cancer patients and others with chronic pain or other diseases, the scientists noted.

They reviewed research and development of drugs based on marijuana and its active ingredient, tetrahydrocannabinol or THC, at the Biophex 2004 conference in San Francisco.

Rick Doblin, president of the Multidisciplinary Association for Psychedelic Studies, which sponsors clinical studies of marijuana-based drugs, said, "It is more difficult to research marijuana than psychedelic drugs like Ecstasy."

Doblin said he has been waiting more than one year to get 10 grams of marijuana from the National Institute on Drug Abuse for a research study at the University of Massachusetts-Amherst.

"The government controls the legal supply," he said.

MARIJUANA FOR MIND AND BODY

In France, however, drugmaker Sanofi-Aventis has a synthetic marijuana-based drug in phase III clinical trials to treat obesity, memory loss and drug dependence, Billy Martin, department chairman of pharmacology and toxicology at Virginia Commonwealth Medical Center, told the conference.

Human bodies have unique "receptors" where marijuana can go to work, relieving pain and inflammation, stimulating appetite, boosting the immune system and helping muscle control, Martin said.

Britain 's GW Pharmaceuticals, a biotechnology company in a marketing deal with Germany's Bayer AG, is developing an oral spray drug, based on the marijuana plant, to treat symptoms of multiple sclerosis and severe pain. It could be sold in Britain and Canada if approved by regulators.

Abrams, a pioneer in the 1980s in fighting AIDS, found that marijuana increased patients' appetites and he began to widen his research on the plant.

Studies show new marijuana drugs have the potential to shrink tumors, enhance the effects of morphine in cancer patients, and treat depression, among other conditions, Abrams said.

"I'm also looking at other botanicals," Abrams added.

Medicines based on the marijuana plant and synthetic marijuana drugs may be delivered to patients in drops, sprays and vaporizers, which could ease fears that smoking the plant may cause lung cancer, the researchers said.

Copyright © 2004 Reuters Limited. All rights reserved. Republication or redistribution of Reuters content, including by framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Reuters and the Reuters sphere logo are registered trademarks and trademarks of the Reuters group of companies around the world.

 

Against Urinary Tract Infections

 

September 30, 2004 11:02:45 AM PDT , HealthDay

 

By Karen Pallarito
HealthDay Reporter

 

THURSDAY, Sept. 30 (HealthDayNews) -- Patients with urinary tract infections (UTIs) often are told to drink cranberry juice to prevent future bladder problems. The advice is rather vague, since there's no data to show how much of the tart beverage people should drink for prevention's sake.

Now there's preliminary evidence to suggest that drinking more is better than drinking less, according to a pilot study being presented Oct. 1 at the annual meeting of the Infectious Diseases Society of America in Boston.

Tannins contained in cranberries interact with the tiny, hair-like protrusions on E. coli bacteria, the most common cause of UTIs. The infection-causing bacteria loose their stickiness and, instead of adhering to the walls of the bladder and causing infection, get washed away in urine.

In the study, researchers found that drinking eight ounces of the juice resulted in a 71 percent reduction in the amount of E. coli bacteria sticking to the bladder walls; a four-ounce serving produced a 33 percent reduction in the unwanted bacteria.

"Eight did basically twice as well as four," said lead investigator Dr. Kalpana Gupta, an assistant professor of medicine/infectious diseases at Yale University School of Medicine.

Two ounces of cranberry juice, however, had no effect in preventing E. coli adherence, she noted. "In our study, it seems here, at least four ounces are needed," said Gupta, who conducted the research when she was with the University of Washington, Seattle, with funding primarily from a National Institutes of Health career development award.

The preventive effect of cranberry juice appears to be dose-dependent. On that finding, researchers have already launched a larger study that will involve many more subjects and compare several different doses of juice.

Even at this preliminary stage, the information gives doctors at least a hint about what to tell their patients with UTIs. "There appears to be no standard amount of cranberry juice recommended, so the information from this study that 'more is better' is useful," said Dr. James Cummings, professor and chief of the division of urology at St. Louis University School of Medicine.

Further research into the cranberry connection could help the millions of Americans who suffer from UTIs, particularly women, who are more prone to getting them. UTIs accounted for more than 8 million doctor visits in 1997, according to the latest data from the National Kidney and Urologic Diseases Information Clearinghouse.

Most people with UTIs experience symptoms, such as a frequent urge to urinate and a painful burning during urination. The problem is treated with antibacterial drugs. For women with recurrent infections, doctors may recommend that they drink plenty of water, urinate when they have the urge, cleanse the genital area before intercourse, and take showers instead of baths to prevent future infections. And some doctors suggest drinking cranberry juice.

Researchers tested cranberry dosing by collecting urine from three symptom-free volunteers before they consumed pre-determined amounts of cranberry juice and four to six hours afterward. The juice they used was a 27 percent cranberry juice cocktail, the kind commonly found on grocery shelves.

Then the investigators incubated E. coli in the urine samples and combined it with human bladder cells to test how well cranberry juice would prevent the bacteria from sticking to those cells. Eight ounces of juice had a twofold greater effect than four ounces.

Does that mean UTI sufferers should drink up? "It's too early to give any advice," Gupta concluded.

Review studies involving mostly healthy young women have shown that cranberry juice may be effective, she said. But it's still not clear exactly how much juice is beneficial, how often UTI sufferers should drink it to prevent recurrences, whether it's effective in other populations, or which juice products contain the appropriate amount of the active tannin needed to prevent infection.

The National Center for Complementary and Alternative Medicine (NCCAM), a unit of the National Institutes of Health, is funding a series of studies that promise to help answer some of those questions. Gail D. Anderson, a professor at the University of Washington School of Pharmacy, is leading one of those studies, which will examine whether cranberry juice interacts with antibiotics used to treat UTIs. Other NCCAM-funded studies will examine efficacy and other safety issues.

Gupta's paper is the first of hopefully many studies to further determine the optimal dosing and efficacy of cranberry juice cocktail, Anderson said.

For now, Gupta suggested that people seeking to prevent UTIs discuss drinking cranberry juice with their doctor.

Consuming too much of the tart stuff isn't really a worry, since most health professionals say cranberry juice is safe. But tolerability is an issue, Anderson noted: "Not everyone likes the taste of cranberry juice."

More information

Visit the National Kidney and Urologic Diseases Information Clearinghouse for more information on urinary tract infections.

 

Back to Original Article : News You Can Use

 

Continue with:

Acne-like rash shows cancer drug is working Last Updated: 2004-09-30 12:26:01 -0400 (Reuters Health) By Patricia Reaney LONDON (Reuters) - An acne-like rash may be good news for colon cancer patients because it shows that a targeted therapy for the disease is working, Belgian scientists said on Thursday. They found that the severity of the rash corresponded to the patient's response to ImClone Systems Inc's drug Erbitux and to the length of their survival.

Gynecologist visit urged before first Pap test Last Updated: 2004-09-30 13:04:01 -0400 (Reuters Health) NEW YORK (Reuters Health) - Adolescent girls should make their first visit to an obstetrician-gynecologist at around 13 to 15 years of age, even though routine Pap testing doesn't usually start until they're older, according to a recommendation from the American College of Obstetricians and Gynecologists (ACOG).

Nighttime dosage cuts high blood pressure in blacks Last Updated: 2004-09-30 15:34:31 -0400 (Reuters Health) NEW YORK (Reuters Health) - A dose of long-acting diltiazem at bedtime is more effective than a morning dose of amlodipine in reducing high blood pressure in black patients, new study findings suggest. The drug works best at reducing blood pressure in the morning -- the time of day when heart attacks and strokes are most likely to occur.

Antibiotics sold illegally in Hispanic NYC stores Last Updated: 2004-09-30 14:28:31 -0400 (Reuters Health) By Megan Rauscher NEW YORK (Reuters Health) - In many Hispanic neighborhoods in New York City, no prescription is needed to get an antibiotic. The drugs are readily available in bodegas and other stores, new survey results indicate.

China , U.S. seek to protect cancer fighting tree Last Updated: 2004-09-30 16:05:32 -0400 (Reuters Health) By Timothy Gardner NEW YORK (Reuters) - The United States and China want to expand trade regulations to protect Asian yew trees, a plant that provides the compound for one of the world's top-selling chemotherapy drugs but is threatened by poaching.

Many Factors Blamed for Childhood Obesity By RANDOLPH E. SCHMID Associated Press Writer WASHINGTON (AP) -- A wide-ranging effort involving parents, schools, communities and government is needed to turn the tide of childhood obesity, the Institute of Medicine said Thursday. "No single factor or sector of society bears all of the blame for the problem," and no sector alone can correct it, Dr. Jeffrey Koplan of Emory University in Atlanta, chairman of the committee that prepared the recommendations, said at a briefing.

Implant Device Appears to Block Strokes By LAURAN NEERGAARD AP Medical Writer WASHINGTON (AP) -- A tiny tent-like device implanted into the heart appears to block strokes caused by a common irregular heartbeat, sealing off a spot where dangerous blood clots form, German and U.S. researchers reported Wednesday.

 

Here are some of the latest health and medical news developments, compiled by editors of HealthDay: Global Stockpile of Bird Flu Vaccine Urged A global effort to create a stockpile of bird flu vaccine is required in order to be ready for a potential pandemic of bird flu, a World Health Organization (WHO) expert warns.

 

 


General Information About Malignant Mesothelioma
Where can I find Asbestos?
Diagnosing Mesothelioma
Asbestos Information
Damages and Settlements
Medical Procedures
Drugs and Medications
Mesothelioma News
Articles       Facts       Charity       Lawyers       Directory       Add a Link       Clinical Trials       State Coverage